LOCUS       LZ129552                  18 bp    RNA     linear   PAT 28-OCT-2017
DEFINITION  JP 2017513485-A/23689: CRISPR/CAS-RELATED METHODS, COMPOSITIONS AND
            COMPONENTS FOR CANCER IMMUNOTHERAPY.
ACCESSION   LZ129552
VERSION     LZ129552.1
KEYWORDS    JP 2017513485-A/23689.
SOURCE      synthetic construct
  ORGANISM  synthetic construct
            other sequences; artificial sequences.
REFERENCE   1  (bases 1 to 18)
  AUTHORS   Bumcrot,D.A., Maeder,M.L., Welstead,G.G. and Friedland,A.E.
  TITLE     CRISPR/CAS-RELATED METHODS, COMPOSITIONS AND COMPONENTS FOR CANCER
            IMMUNOTHERAPY
  JOURNAL   Patent: JP 2017513485-A 23689 01-JUN-2017;
            EDITAS MEDICINE INC,G Grant WELSTEAD,Ari E FRIEDLAND,Morgan L
            MAEDER, David A BUMCROT
COMMENT     OS   Artificial Sequence
            PN   JP 2017513485-A/23689
            PD   01-JUN-2017
            PF   17-APR-2015 JP 2016562958
            PR   18-APR-2014 US 61/981636           ,25-MAR-2015 US 62/138246
            PA   EDITAS MEDICINE INC,G Grant WELSTEAD,Ari E FRIEDLAND,Morgan L
            PA   MAEDER,
            PA   David A BUMCROT
            PI   david a bumcrot,morgan l maeder,g grant welstead,ari e
            PI   friedland
            PT   "CRISPR/CAS-RELATED METHODS, COMPOSITIONS AND COMPONENTS FOR
            PT   CANCER
            PT   IMMUNOTHERAPY"
            PS   N24044
            CC   Synthetic oligonucleotide: Ptpn6-4618
            FH   Key             Location/Qualifiers
FEATURES             Location/Qualifiers
     source          1..18
                     /mol_type="unassigned RNA"
                     /db_xref="taxon:32630"
                     /organism="synthetic construct"
BASE COUNT            1 a            5 c            7 g            5 t
ORIGIN      
        1 gggggtgtcc tcagcttc
//